Literature DB >> 14678212

Systemic acyclovir reaction subsequent to acyclovir contact allergy: which systemic antiviral drug should then be used?

C Vernassiere1, A Barbaud, P H Trechot, F Weber-Muller, J L Schmutz.   

Abstract

Allergic contact dermatitis caused by acyclovir is rare. We report the 5th case of systemic acyclovir reaction subsequent to acyclovir contact dermatitis, with investigations made to determine an alternative antiviral treatment. A 23-year-old woman, after dermatitis while using Zovirax cream, went on to develop urticaria after oral acyclovir. Patch tests were performed with the components of Zovirax cream (acyclovir, propylene glycol and sodium lauryl sulfate) and with other antiviral drugs. Patch tests were positive to Zovirax cream, acyclovir, valacyclovir and propylene glycol. Patch and prick tests with famciclovir were negative, but its oral administration caused an itchy erythematous dermatitis on the trunk and extremities. Our patient developed a systemic acyclovir reaction subsequent to acyclovir allergic contact dermatitis, with cross-reactions to valacyclovir and famciclovir. Their common chemical structure is the 2-aminopurine nucleus. It is probably this part of the molecule that provokes both contact allergy and systemic reactions. The only antiviral drugs not having this core are foscarnet and cidofovir, and these could therefore be alternatives.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14678212     DOI: 10.1111/j.0105-1873.2003.00199.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  3 in total

1.  Rapid Desensitization for Acyclovir Hypersensitivity.

Authors:  Simran Jain; Gouri Rao Passi
Journal:  Indian J Pediatr       Date:  2019-06-17       Impact factor: 1.967

2.  Acyclovir Has Low but Detectable Influence on HLA-B*57:01 Specificity without Inducing Hypersensitivity.

Authors:  Imir G Metushi; Amanda Wriston; Priyanka Banerjee; Bjoern Oliver Gohlke; A Michelle English; Andrew Lucas; Carrie Moore; John Sidney; Soren Buus; David A Ostrov; Simon Mallal; Elizabeth Phillips; Jeffrey Shabanowitz; Donald F Hunt; Robert Preissner; Bjoern Peters
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

3.  Adverse drug reactions triggered by the common HLA-B*57:01 variant: virtual screening of DrugBank using 3D molecular docking.

Authors:  George Van Den Driessche; Denis Fourches
Journal:  J Cheminform       Date:  2018-01-30       Impact factor: 5.514

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.